Xin Li Jiahua Xu Xiaoqiang Gu Ling Chen Qing Wu Hongwei Li Haoran Bai Jinzu Yang Jianxin Qian
10.3389/fimmu.2021.740790
Front Immunol
2021 Oct 18;12:740790.
antiangiogenic therapy case report cryoablation hepatocellular carcinoma immune checkpoint inhibitors
CC BY
https://pubmed.ncbi.nlm.nih.gov/34733279/
Antibodies, Monoclonal, Humanized / therapeutic use Antineoplastic Combined Chemotherapy Protocols / therapeutic use Carcinoma, Hepatocellular / therapy Immune Checkpoint Inhibitors / therapeutic use Immunotherapy / methods Liver Neoplasms / therapy Neovascularization, Pathologic / drug therapy Phenylurea Compounds / therapeutic use Quinolines / therapeutic use
Antibodies, Monoclonal, Humanized / therapeutic use Antineoplastic Combined Chemotherapy Protocols / therapeutic use Carcinoma, Hepatocellular / therapy Immune Checkpoint Inhibitors / therapeutic use Immunotherapy / methods Liver Neoplasms / therapy Neovascularization, Pathologic / drug therapy Phenylurea Compounds / therapeutic use Quinolines / therapeutic use Case Reports Research Support, Non-U.S. Gov't Adult Combined Modality Therapy Cryosurgery Humans Male Neoplasm Metastasis Neoplasm Recurrence, Local Remission Induction Antibodies, Monoclonal, Humanized Immune Checkpoint Inhibitors Phenylurea Compounds Quinolines toripalimab lenvatinib
PMC8559549
34733279
Case Report: Antiangiogenic Therapy Plus Immune Checkpoint Inhibitors Combined With Intratumoral Cryoablation for Hepatocellular Carcinoma
2021